Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
SEC
'Misleading, Fallacious': Government On Media Reports Claiming Covaxin Approval Was Rushed Due To Political Pressure
Swarajya Staff
Nov 17, 2022 02:09 PM +05:30 IST
Explained: Why Chinese Companies Are Delisting From US Stock Exchanges
Swarajya Staff
Aug 22, 2022 11:48 AM +05:30 IST
Full Market Approval For Covishield, Covaxin: DCGI Panel To Meet Again Soon To Review Proposals
Swarajya Staff
Jan 15, 2022 03:23 PM +05:30 IST
Govt's Expert Panel Recommends Emergency Use Approval For Zydus' ZyCoV-D, Second Indigenous COVID Vaccine: Report
Swarajya Staff
Aug 20, 2021 01:46 PM +05:30 IST
U.S Crackdowns On Chinese IPOs Over Use Of 'Shell Companies', Stops Processing Registration Of IPOs Till New Regulatory Framework Is Set Up
Swarajya Staff
Jul 31, 2021 02:10 PM +05:30 IST
DCGI's Expert Panel Says No To Covovax Trials On Children, Asks Serum Institute To Submit Safety Data First
Swarajya Staff
Jul 1, 2021 02:22 PM +05:30 IST
Hetero Gets DCGI's Expert Panel Nod To Conduct Phase 3 Trials Of Russian Sputnik V Covid Vaccine In India
Swarajya Staff
Apr 30, 2021 10:24 AM +05:30 IST
India Gets Third Covid-19 Vaccine As DCGI Approves Use Of Russian Sputnik V After Expert Panel's Recommendation
Swarajya Staff
Apr 13, 2021 08:06 AM +05:30 IST
Indian Drug Regulator's Expert Panel Asks For More Data To Recommend Emergency Use Of Russian Sputnik V COVID-19 Vaccine
Swarajya Staff
Apr 2, 2021 08:49 AM +05:30 IST
Bharat Biotech Plans Covaxin Testing On Children As Young As Two Years; To Submit A Proposal To DCGI's Expert Panel Soon
Swarajya Staff
Jan 5, 2021 11:38 AM +05:30 IST
Boost To India's Fight Against Covid-19: Emergency Use Approval Recommended For SII's Covishield, Bharat Biotech's Covaxin
Swarajya Staff
Jan 3, 2021 08:20 AM +05:30 IST
Bharat Biotech Set To Begin Phase 3 Clinical Trials Of Its Indigenous Covid-19 Vaccine 'Covaxin', Seeks DCGI Nod
Swarajya Staff
Oct 9, 2020 09:38 AM +05:30 IST
Goa Government To Make Wearing Of Masks Mandatory For Purchase Of Petrol, Rations
IANS
Apr 30, 2020 05:01 PM +05:30 IST
The Musk Is Off, It Seems: As US Stock Regulator Sues Tesla CEO For ‘Fraud’, Company Shares Plunge 13 Per Cent
Swarajya Staff
Sep 28, 2018 09:17 AM +05:30 IST
Panchayat Polls: Bid To Browbeat Opposition Is Blowing Up In Trinamool’s Face
Jaideep Mazumdar
Apr 19, 2018 01:31 PM +05:30 IST
With A Value Mark-Down To $5.5 Billion, Flipkart Is Now Ripe For Takeover
R Jagannathan
Dec 1, 2016 12:05 PM +05:30 IST
Load More